A Run to Remember: Disneyland to Disney World, and Beyond
Don’s courageous effort of doing something extraordinary shows that people living with T1D truly can do anything that they put…
50+ Years with Type 1: An Interview with Dr. George King
I got the privilege of interviewing George King, M.D., whose research is on diabetes complications. Breakthrough T1D has funded him…
Bigfoot Is Real—and Received FDA Clearance
The Bigfoot Unity™ Diabetes Management by Bigfoot Biomedical received FDA clearance for individuals 12 and older.
At 37, I’m Fighting to Save my Eyesight
At the age of 37, I’m fighting to save my eyesight, a complication of type 1. People are also at…
National DNA Day!
Aaron Michels, M.D., discovered that methyldopa—a therapy that has been used for 50 years to treat high blood pressure—may have…
You’re a Mathematician! No, I Just Have Type 1 Diabetes
It’s not an overstatement to say that, to effectively manage type 1 diabetes, one needs to be a mathematician. (Keep…
FDA Breakthrough Therapy Designation for TTP399—A Potential First-in-Class Adjunct Therapy in T1D
The FDA granted Breakthrough Therapy designation for vTv Therapeutics’ TTP399 as an adjunct therapy to insulin for T1D.
(Beta Cell) Stressing You Out?
You thought that beta cells were passive participants in their own immune-mediated death, leading to type 1 diabetes (T1D)? Wrong.
Mourning the Loss of a Breakthrough T1D Champion and Friend
There’s nothing bad you can say about John J. McDonough. He was a self-made man. He served on Breakthrough T1D’s…
Severe Low Blood Sugar: There’s a New Treatment Option
The FDA approved Zegalogue® (dasiglucagon) injection, for the treatment of severe hypoglycemia in children and adults with diabetes aged 6…
